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The Value of Quick Sepsis-Related Organ Failure
Assessment Scores in Patients With Acute Pancreatitis
Who Present to Emergency Departments:
A Three-Year Cohort Study
Alexander Hallaca, b, Nishant Puria, e, David Appleburya, Kurt Myersb,
Parag Dhumalc, Ashish Thatted, Wichit Srikurejaa

Abstract
Background: Distinguishing sepsis from other inflammatory syndromes continues to be a clinical challenge. The goal of risk stratification tools is to differentiate sepsis from other conditions. We compare
the ability of quick sepsis-related organ failure assessment (qSOFA)
and systemic inflammatory responses syndrome (SIRS) scores to predict prolonged length of stay (LOS) among patients who presented to
the emergency department and hospital ward with acute pancreatitis
(AP).
Methods: We compiled a retrospective database of all adult patients
hospitalized for AP during 2015 - 2018 at a single tertiary care center.
Independent t-tests, Pearson’s correlation and multiple regressions
were performed with hospital LOS as the dependent variable, versus
demographic characteristics and etiology of the pancreatitis as independent variables. Prolonged LOS was defined as > 5 days.
Results: The sensitivity and specificity of an SIRS score of 2 or greater for the detection of patients with prolonged LOS were 61% and
80%, respectively. The qSOFA score of 2 or greater corresponded to
a diagnosis of significant AP with a specificity of 99% and a sensitivity of 4%. Multiple regression analysis demonstrated that each point
increase in an SIRS score is associated with 2.24 days in additional
hospital LOS. Interestingly, SIRS scores were found to correlate with
the LOS, but not qSOFA.
Conclusion: The qSOFA is a tool designed to identify patients at high
risk of mortality due to sepsis. The data suggest that as with sepsis,
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patients with AP who are triaged with only qSOFA could be underrecognized and subsequently undertreated. Secondarily, the data suggest that SIRS scoring has the potential to promptly predict how long
patients with AP will stay in the hospital.
Keywords: Pancreatitis; Sepsis; Systemic inflammatory response
syndrome; Emergency department; Triage

Introduction
Sepsis is a syndrome of life-threatening organ dysfunction
caused by a dysregulated host response to infection. Sepsis is
diagnosed in approximately 1.7 million adults in the USA annually and possibly implicated in up to half of all inpatient hospital deaths [1-3]. The high prevalence and mortality of Sepsis
syndrome make it the most expensive condition treated in US
hospitals with an estimated yearly cost of $24 billion to the US
health care system [4]. The identification of sepsis and characterization of the sepsis syndrome in the current era of highly
protocolized patient care is rapidly evolving. Constructing risk
stratification tools and care pathways involves integration of
translational research, clinical trials and large electronic health
record (EHR) datasets. As a result, developing best practices
for sepsis is an onerous task with many stakeholders. This task
was recently undertaken by a 19-member task force sponsored
by the Society of Critical Care Medicine and the European
Society of Intensive Care Medicine, and the end result was
sepsis-3 [1]. The consensus of the committee included the
de-emphasizing of the systemic inflammatory responses syndrome (SIRS) criteria which was established as the prominent
precursor/indicator of impending sepsis/infection [5]. Sepsis-3
concluded that utilizing SIRS criteria identifies many patients
who are undergoing a physiological response to non-infectious
etiologies of sepsis [1, 5].
Sepsis-3 proposes the use of a non-laboratory based alternative to the sepsis-related organ failure assessment (SOFA)
score named quick SOFA (qSOFA) for mortality prediction
in patients thought to be infected. The qSOFAs is to be used
immediately upon a patient’s presentation to clinicians both
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Table 1. Frequency and Associated Lengths of Hospital Stay for Common Causes of Acute Pancreatitis
Etiology

Frequency

Mean length of stay (days)

Idiopathica

81

5.2

Alcohol-induceda

75

4.8

Choledocholithiasisb

58

4.5

Mass/obstruction inducedb

26

4.6

15

4.3

12

3.1

Post-ERCP

pancreatitisa

Hypertriglyceridemiaa
Pancreatic

divisumb

8

2.6

Other

10

3.5

Total

285

aNon-mechanical. bMechanical. Other: cystic fibrosis, sphincter of Oddi dysfunction, drug-induced and ischemic pancreatitis. ERCP: endoscopic
retrograde cholangiopancreatography.

inside and outside of the emergency department (Table 1) [1,
6]. The SOFA and qSOFA are notably meant to be used on
patients with a presumed infection; however, on initial examination, infection status is not always clear. Although qSOFA
is embraced by much of the professional community, there is
concern with the de-emphasis of SIRS most notably by the
American College of Chest Physicians (ACCP) [7].
We aim to assess the sensitivity and specificity of initial
assessments with qSOFA and SIRS ability to identify and stratify emergency room patients with acute pancreatitis (AP) who
had prolonged hospital stay.

Methods
The Spokane Institutional Review Board approved (which acts
in accordance with Helsinki Declaration of 1975 as revised in
2000) the development of a retrospective database comprised
of all adult patients (18 years or greater) hospitalized with a
diagnosis of AP during 2015 - 2018. The database was created
with full ethical compliance as a human study. The Institutional Review Board granted an exception on informed consent
given the retrospective nature of the study. The sample size
and retrospective time frame was determined based on a predetermined goal of analyzing over 200 subjects. The database
was constructed using Current Procedural Terminology (CPT)
codes to identify all cases of AP at a single tertiary care center.
The diagnosis of AP requires at least two of the following features: characteristic abdominal pain; biochemical evidence of
pancreatitis (i.e. amylase or lipase elevated > 3 times the upper
limit of normal); and/or radiographic evidence of pancreatitis
on cross-sectional imaging [8, 9]. Diagnostic data including
vital signs and laboratory studies along with demographic and
disposition data were electronically and manually extracted
from EHR. Manual data extraction was performed by trained
physician researchers who followed strict protocols and did
not participate in the admission of patients within the cohort.
This retrospective cohort study was reported in accordance
with the STROBE statement [10].
The vital signs analyzed were the first recordings obtained
in the emergency room and the laboratory data analyzed were
68

the first lab values obtained, frequently within 3 h of hospital
arrival. The patient’s Glasgow coma scale and mental status
were determined by physician investigators (DA and KM), as
well as interpretation of the emergency department documentation, emergency department impressions, hospital history
and physical problem lists. In order to prevent potential bias by
the physician investigators, a third physician investigator was
available for consultation. The qSOFA criteria were defined:
altered mental status (AMS); respiratory rate (RR) ≥ 22/min;
and systolic blood pressure (SBP) ≤ 100 mm Hg. The SIRS
criteria were defined: heart rate (HR) ≥ 90 bpm; white blood
cell (WBC) ≥ 12,000/µL or ≤ 4,000/µL; RR ≥ 20/min; and
temperature ≥ 38.5 °C or ≤ 36 °C. The aforementioned criteria
were used to establish qSOFA and SIRS scores as intended by
the authors of each scoring system [1, 5]. Significant AP was
defined as patients who had hospital lengths of stay (LOS) that
extended beyond the cohorts median LOS (5 days). The specificity and sensitivity of SIRS and qSOFA’s ability to determine
which patients would have significant AP were calculated. The
etiology of AP was categorized as mechanical (gallstone, mass
and ductal disturbance) and non-mechanical (alcohol, post-endoscopic retrograde cholangiopancreatography and hypertriglyceridemia). Cystic fibrosis, sphincter of Oddi dysfunction,
drug-induced and ischemic pancreatitis were the least common
etiologies and together composed the “other” category.
All statistical analysis was performed using IBM SPSS
Statistics for Windows, version 24 (IBM Corp., Armonk, NY,
USA). Statistical tests included independent sample t-test, Pearson’s correlation and multiple regressions performed with LOS
as the dependent variable and all other variables as independent
variables.

Results
Three hundred seventy-six patients populated from the EHR
search, and 285 had a hospital admission for AP that met the
inclusion criteria. The 91 patients who did not meet inclusion
criteria lacked sufficient clinical data or documentation while
in the emergency department for analysis in this study. The
classification of significant AP applied to 23 patients. The
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Table 2. Sensitivity and Specificity of qSOFA in Detecting Prolonged Length of Hospital Stay
qSOFA
1

Significant acute pancreatitis

Total

Sensitivity

Specificity

False positive

44

50

0.26

0.83

0.17

4

0.04

0.99

0.01

Yes

No

6

2

1

3

Total

23

262

qSOFA: quick sepsis-related organ failure assessment.

mean age of the subjects in the study was 51 years (range: 18
- 98), and a majority were men (n = 147, 51.5%). The mean
numbers of days spent by male and female patients are 4.86
and 4.38, respectively. Independent sample t-test showed no
difference in the LOS based on gender (t = 0.45; P = 0.64).
Pearson’s correlation between the patients age and LOS was
not significant (r = 0.61; P = 0.30).
The prevalence of current smokers was 30.5% (n = 87), although 29.4% (n = 84) reported a history of smoking. One-way
ANOVA test demonstrated no difference in the average LOS
based on current smoking status (F = 0.27; P = 0.76).
Seventy-two of the 285 (25.2%) patients had prior hospital
admissions for AP prior to the start of this study. The average
numbers of days spent by patients with non-recurrent and recurrent pancreatitis are 4.8 and 3.9, respectively. Independent sample t-test showed no difference in the LOS (t = 0.78; P = 0.43).
Alcohol was the most prevalent known etiology of AP (n =
75, 26%) followed by gallstone pancreatitis (n = 58, 20%) (Table
1). No specific etiology was found to have a statistically significant impact on the LOS (ANOVA: F = 0.18; P = 0.98) (Table 1).
The mean LOS of patients in the non-mechanical and mechanical category are 4.69 and 4.53, respectively. No difference in the
LOS was demonstrated between these categories (t = 0.148; P
= 0.88). Each patient’s entire hospital course was reviewed, and
no patients expired secondary to AP during our study.

qSOFA
No patients in the study met all three qSOFA criteria. The qSOFA score of 2 was present in four patients and corresponded to
a diagnosis of significant AP with a specificity of 99% and a
sensitivity of 4% (Table 2, Fig. 1). No patients with AP secondary to a mechanical etiology met two qSOFA criteria. Twentyone patients with AP induced by a mechanical etiology met
one qSOFA criterion, which diagnosed significant AP with a
sensitivity of 18% and a specificity of 81%. The mean qSOFA
scores for non-mechanical and mechanical etiologies are 0.93
and 0.83, and these differences did not influence the LOS (t =
-0.55; P = 0.57).
SIRS
The specificity and sensitivity of an SIRS score of 2 for the
detection of patients with significant AP were 61% and 80%,
respectively (Table 3, Fig. 2). The diagnosis of significant AP
secondary to a non-mechanical etiology in a patient with an
SIRS score of 2 had a sensitivity of 58% and a specificity of
78% (Fig. 1). The SIRS score of 2 had a sensitivity of 64% and
a specificity of 83% in diagnosing significant AP in patients
with AP secondary to a mechanical etiology (Fig. 1).

Figure 1. The receiver operating curve demonstrates the sensitivity and specificity of quick sepsis-related organ failure assessment (qSOFA) scoring in detecting significant acute pancreatitis. The underlying mechanism of pancreatitis is mechanical or
non-mechanical, and both are individually and collectively analyzed.
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Table 3. Sensitivity and Specificity of the SIRS in Detecting Prolonged Length of Hospital Stay
Significant acute pancreatitis

SIRS
1

Yes

No

19

151

Total

Sensitivity

Specificity

False positive

170

0.83

0.42

0.58

2

14

52

66

0.61

0.80

0.20

3

3

13

16

0.13

0.95

0.05

4

2

0

2

0.09

1.00

0.00

Total

23

262

SIRS: systemic inflammatory responses syndrome.

Multiple regression analysis demonstrated that the effect
of qSOFA and SIRS on LOS is significant (R2 = 4.8%; F =
8.216; P = 0.0001). Individual testing of the effect that qSOFA
had on LOS was not significant (t = -0.415; P= 0.678). Regression testing of SIRS effect on LOS was significant (R2 = 5.4%;
F = 16.307; P = 0.0001; t = 4.038; P = 0.0001). SIRS scores
account for 5.4% of the variability in the mean LOS of patients
with AP. Each point increase in a patient SIRS score adds 2.24
days in hospital LOS.

Discussion
Although AP is very common and the understanding of the
pathophysiology continues to evolve, the management of patients with AP has moved at a glacial speed, remaining largely
unchanged for many years.
Over the last half century, numerous risk stratifying tools
have been developed, including nine of which Mounzer et al
analyzed and determined they had modest diagnostic accuracy
(area under curve (AUC) at hospital presentation of 0.6 - 0.8 in
two cohorts) [11]. Risk stratifying calculations have fallen out
of favor in clinical practice; however, categorization of AP is

occasionally assigned by the revised Atlanta classification [8,
9]. The development of a superior risk stratifying tool for AP is
unlikely until novel diagnostic and therapeutic options for the
treatment of AP are enacted.
The absence of a leading AP risk stratification tool and
the variability of patient presentation often result in patients
being triaged and risk stratified using sepsis scoring systems.
Although neither SIRS nor qSOFA is designed to diagnose AP,
both sepsis and AP share similar physiology and intravenous
fluid resuscitation is a cornerstone of initial management.
Sepsis-3 has many critics including the ACCP who are
concerned that the recommendation to retire SIRS criteria
could blind clinicians to patients who are early in the continuum of sepsis [7]. An initial qSOFA could falsely reassure clinicians during triage allowing for a delay in performing valuable
interventions that may alter the course of a patient’s pancreatitis potentially allowing for progression to organ failure.
There is concern that the transition to implementing the
qSOFA tool and other elements of the sepsis-3 will negatively
affect sepsis management due to the difficulty of appropriately
utilizing and implementing this tool in such a complex syndrome. The intended use of qSOFA is to screen for high-risk
patients with a presumed infection requiring aggressive man-

Figure 2. The receiver operating curve demonstrates the sensitivity and specificity of systemic inflammatory response syndrome
(SIRS) scoring in detecting significant acute pancreatitis. The underlying mechanism of pancreatitis is mechanical or non-mechanical, and both are individually and collectively analyzed.
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agement in the emergency department and hospital settings;
however, it could falsely reassure providers when other pathologies are the causes of illness [1].
Our results demonstrated a sensitivity of 4% and a specificity of 99% in the ability of qSOFA to predict patients with
significant AP. These same patients in the absence of other
diagnostic information would be unlikely to have undergone
appropriate intravenous fluid resuscitation due to inadequate
identification and triage.
SIRS was superior to qSOFA in predicting patients with
prolonged hospital stays as shown in Figure 2. Interestingly,
SIRS scores were found to correlate with the LOS in our study,
for each point on the SIRS score 2.24 days of hospitalization
was predicted. This finding is useful in counseling patients on
their predicted hospital course at the time of hospital presentation. The utility of SIRS as a diagnostic tool for significant AP
is far from optimal with a sensitivity of 61% and a specificity
80%.
The limitation of this study beyond the retrospective design is the homogeneity of a single center study. The absence
of patients who expired secondary to AP may decrease the generalizability of this study to practitioners at centers with high
mortality rates. Although qSOFA is designed for risk stratification of sepsis and is not intended for AP, both pathologies have
similar initial management. We believe our data represent the
potential risk of undertreating patients with AP who are triaged
using the novel qSOFA criteria instead of the SIRS criteria.
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